HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Taskiran, M. Articles by Hilsted, J. Search for Related Content PubMed PubMed Citation Articles by Taskiran, M. Articles by Hilsted, J. Social Bookmarking                What's this?

Decreased Myocardial Perfusion Reserve in Diabetic Autonomic Neuropathy

¹ Department of Endocrinology, H:S Hvidovre University Hospital, Copenhagen, Denmark
² Department of Magnetic Resonance, H:S Hvidovre University Hospital, Copenhagen, Denmark
³ Department of Cardiology, H:S Hvidovre University Hospital, Copenhagen, Denmark

The pathophysiological mechanisms responsible for increased cardiovascular mortality in diabetic autonomic neuropathy are unknown. To investigate the effect of autonomic neuropathy on myocardial function, we performed dynamic contrast-enhanced magnetic resonance perfusion imaging during baseline conditions and after Dipyridamole-induced vasodilatation in nine type 1 diabetic patients with autonomic neuropathy (AN+), defined by cardiovascular tests, as well as in 10 type 1 diabetic patients without autonomic neuropathy (AN-) and 10 healthy control subjects. Baseline myocardial perfusion index (K_i) was similar in the three groups (AN+ 88.6 ± 8.7 ml · 100 g^-1 · min^-1, AN- 82.6 ± 7.2, control subjects 93.7 ± 9.0) (means ± SE). K_i during Dipyridamole vasodilatation was significantly lower in the patients with autonomic neuropathy (P < 0.001) than in the other groups (AN+ 131.1 ± 13.0 ml · 100 g^-1 · min^-1, AN- 177.3 ± 8.6, control subjects 197.2 ± 8.9). Mean blood pressure was unchanged during Dipyridamole infusion in AN- and control subjects, whereas a significant blood pressure decrease was found in AN+ (15.6 ± 2.6 mmHg, P < 0.025). There was a significant correlation between blood pressure response to Dipyridamole and myocardial perfusion reserve index. We conclude that type 1 diabetic patients with autonomic neuropathy have a decreased myocardial perfusion reserve capacity when challenged with a vasodilatator, a finding that may in part be the pathophysiological substrate for the increase in mortality in these patients. The underlying mechanism may be defective myocardial sympathetic vasodilatation, a lack of ability to maintain blood pressure during vasodilatation, or both.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				P. A. Senior, R. C. Welsh, C. G. McDonald, B. W. Paty, A.M. J. Shapiro, and E. A. Ryan Coronary Artery Disease Is Common in Nonuremic, Asymptomatic Type 1 Diabetic Islet Transplant Candidates Diabetes Care, April 1, 2005; 28(4): 866 - 872. [Abstract] [Full Text] [PDF]

				Z. Y. Fang, J. B. Prins, and T. H. Marwick Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications Endocr. Rev., August 1, 2004; 25(4): 543 - 567. [Abstract] [Full Text] [PDF]